Exact Mass: 733.5645

Exact Mass Matches: 733.5645

Found 204 metabolites which its exact mass value is equals to given mass value 733.5645, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PC(16:0/16:0)

(R)-4-Hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-oxide hydroxide inner salt

C40H80NO8P (733.5621)


PC(16:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/16:0), in particular, consists of two chains of palmitic acid at the C-1 and C-2 positions. The palmitic acid moieties are derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Dipalmitoylphosphatidylcholine (DPPC) is the major constituent of pulmonary surfactant. It is also used for research purposes in studying liposomes, lipid bilayers, and model biological membranes. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/16:0), in particular, consists of two chains of palmitic acid at the C-1 and C-2 positions. The palmitic acid moieties are derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Dipalmitoylphosphatidylcholine (DPPC) is the major constituent of pulmonary surfactant. It is also used for research purposes in studying liposomes, lipid bilayers, and model biological membranes. R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AA - Lung surfactants C78273 - Agent Affecting Respiratory System DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers[1]. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in mice[2].

   

PC(14:0/18:0)

trimethyl(2-{[(2R)-2-(octadecanoyloxy)-3-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C40H80NO8P (733.5621)


PC(14:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/18:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of stearic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(14:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/18:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of stearic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:0/14:0)

trimethyl(2-{[(2R)-3-(octadecanoyloxy)-2-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C40H80NO8P (733.5621)


PC(18:0/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/14:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of myristic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:0/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/14:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of myristic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(15:0/20:0)

(2-aminoethoxy)[(2R)-2-(icosanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphinic acid

C40H80NO8P (733.5621)


PE(15:0/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/20:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(15:0/20:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(15:0/20:0), in particular, consists of one pentadecanoyl chain to the C-1 atom, and one eicosanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(20:0/15:0)

(2-aminoethoxy)[(2R)-3-(icosanoyloxy)-2-(pentadecanoyloxy)propoxy]phosphinic acid

C40H80NO8P (733.5621)


PE(20:0/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/15:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(20:0/15:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(20:0/15:0), in particular, consists of one eicosanoyl chain to the C-1 atom, and one pentadecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE-NMe(16:0/18:0)

[3-(hexadecanoyloxy)-2-(octadecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C40H80NO8P (733.5621)


PE-NMe(16:0/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/18:0), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one octadecanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(14:0/20:0)

[2-(icosanoyloxy)-3-(tetradecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C40H80NO8P (733.5621)


PE-NMe(14:0/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:0/20:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(18:0/16:0)

[2-(hexadecanoyloxy)-3-(octadecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C40H80NO8P (733.5621)


PE-NMe(18:0/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/16:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(20:0/14:0)

[3-(icosanoyloxy)-2-(tetradecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C40H80NO8P (733.5621)


PE-NMe(20:0/14:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/14:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(15:0/18:0)

[2-(dimethylamino)ethoxy][2-(octadecanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphinic acid

C40H80NO8P (733.5621)


PE-NMe2(15:0/18:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(15:0/18:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(18:0/15:0)

[2-(dimethylamino)ethoxy][3-(octadecanoyloxy)-2-(pentadecanoyloxy)propoxy]phosphinic acid

C40H80NO8P (733.5621)


PE-NMe2(18:0/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:0/15:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

1,2-Dipalmitoylphosphatidylcholine

(2-{[2,3-bis(hexadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C40H80NO8P (733.5621)


   

Linckiacerebroside A

Linckiacerebroside A

C40H79NO10 (733.5704)


   

1-O-TBSA-2-O-palmitoyl-sn-phosphotidylethanolamine|1-O-tuberculostearoyl-2-O-palmitoyl-sn-glycero-3-phosphoethanolamine

1-O-TBSA-2-O-palmitoyl-sn-phosphotidylethanolamine|1-O-tuberculostearoyl-2-O-palmitoyl-sn-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

Phosphatidylcholine 16:0-16:0

1,2-DIHEXADECANOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE

C40H80NO8P (733.5621)


   

PC 32:0

1-heptadecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C40H80NO8P (733.5621)


Found in mouse lung; TwoDicalId=6; MgfFile=160901_Lung_AA_Neg_17_never; MgfId=1093

   

Colfosceril palmitate

(2-{[2.3-bis(hexadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C40H80NO8P (733.5621)


R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AA - Lung surfactants C78273 - Agent Affecting Respiratory System DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers[1]. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in mice[2].

   

(2-{[2.3-bis(hexadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

(2-{[2.3-bis(hexadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C40H80NO8P (733.5621)


   

PC(13:0/19:0)

3,5,8-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotridecyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C40H80NO8P (733.5621)


   

PC(13:0/19:0)[U]

3,5,8-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotridecyl)oxy]methyl]-, inner salt, 4-oxide

C40H80NO8P (733.5621)


   

PC(14:0/18:0)[U]

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotetradecyl)oxy]methyl]-, inner salt, 4-oxide

C40H80NO8P (733.5621)


   

PC(15:0/17:0)

3,5,8-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxopentadecyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C40H80NO8P (733.5621)


   

PC(15:0/17:0)[U]

3,5,8-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxopentadecyl)oxy]methyl]-, inner salt, 4-oxide

C40H80NO8P (733.5621)


   

Dipalmitoyl phosphatidylcholine

1,2-dihexadecanoyl-sn-glycero-3-phosphocholine

C40H80NO8P (733.5621)


   

PC(16:0/16:0)[U]

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxohexadecyl)oxy]-, inner salt, 4-oxide, (-)-

C40H80NO8P (733.5621)


   

PC(17:0/15:0)

3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxopentadecyl)oxy]-, inner salt, 4-oxide, (R)-

C40H80NO8P (733.5621)


   

PC(17:0/15:0)[U]

3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxopentadecyl)oxy]-, inner salt, 4-oxide

C40H80NO8P (733.5621)


   

PC(18:0/14:0)[U]

Myristin, 1-stearo-2-, dihydrogen phosphate, monoester with choline hydroxide, inner salt

C40H80NO8P (733.5621)


   

PC(19:0/13:0)

3,5,9-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotridecyl)oxy]-, inner salt, 4-oxide, (R)-

C40H80NO8P (733.5621)


   

PC(20:0/12:0)

3,5,9-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxododecyl)oxy]-, inner salt, 4-oxide, (R)-

C40H80NO8P (733.5621)


   

PC(20:0/12:0)[U]

3,5,9-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxododecyl)oxy]-, inner salt, 4-oxide, (1)-

C40H80NO8P (733.5621)


   

PC(21:0/11:0)

3,5,9-Trioxa-4-phosphatriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoundecyl)oxy]-, inner salt, 4-oxide, (R)-

C40H80NO8P (733.5621)


   

PC(22:0/10:0)

3,5,9-Trioxa-4-phosphahentriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxodecyl)oxy]-, inner salt, 4-oxide, (R)-

C40H80NO8P (733.5621)


   

PC(9:0/23:0)

3,5,8-Trioxa-4-phosphahentriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxononyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C40H80NO8P (733.5621)


   

PE(17:0/18:0)[U]

Octadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxoheptadecyl)oxy]ethyl ester

C40H80NO8P (733.5621)


   

PE(19:0/16:0)

Nonadecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxohexadecyl)oxy]propyl ester, (R)-

C40H80NO8P (733.5621)


   

PE(19:0/16:0)[U]

Nonadecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxohexadecyl)oxy]propyl ester

C40H80NO8P (733.5621)


   

PE(16:0/19:0)

Nonadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester, (R)-

C40H80NO8P (733.5621)


   

PE(16:0/19:0)[U]

Nonadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester

C40H80NO8P (733.5621)


   

PE(20:0/15:0)[U]

1-Eicosanoyl-2-pentadecanoyl-sn-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

PE(18:0/17:0)[U]

1-octadecanoyl-2-heptadecanoyl-sn-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

PE(13:0/22:0)[U]

1-tridecanoyl-2-docosanoyl-sn-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

PE(14:0/21:0)[U]

1-tetradecanoyl-2-heneicosanoyl-sn-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

GPEtnNMe(17:0/17:0)[U]

Heptadecanoic acid, 1-[[[hydroxy[2-(methylamino)ethoxy]phosphinyl]oxy]methyl]-1,2-ethanediyl ester

C40H80NO8P (733.5621)


   

PE(18:0(10(R)Me)/16:0)

1-TBSA-2-palmitoyl-sn-glycero-3-phosphoethanolamine, 1-tuberculostearoyl-2-palmitoyl-sn-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

Lecithin

1-Stearoyl-2-myristoyl-sn-glycero-3-phosphocholine

C40H80NO8P (733.5621)


   

PE(35:0)

1-Arachidonyl-2-pentadecanoyl-sn-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

PE(13:0/22:0)

1-tridecanoyl-2-docosanoyl-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

PE(14:0/21:0)

1-tetradecanoyl-2-heneicosanoyl-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

PE(18:0/17:0)

1-octadecanoyl-2-heptadecanoyl-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

PE(22:0/13:0)

1-docosanoyl-2-tridecanoyl-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

PE(21:0/14:0)

1-heneicosanoyl-2-tetradecanoyl-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

PE(17:0/18:0)

1-heptadecanoyl-2-octadecanoyl-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

PE 35:0

Nonadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester, (R)-

C40H80NO8P (733.5621)


   

L-1-Phosphatidylethanolamine

L-1-Phosphatidylethanolamine

C40H80NO8P (733.5621)


   

N-(2-hydroxyheptadecanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

N-(2-hydroxyheptadecanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

C40H79NO10 (733.5704)


   

1-Myristoyl-2-stearoylphosphatidylcholine

1-Myristoyl-2-stearoylphosphatidylcholine

C40H80NO8P (733.5621)


   

(3-Octanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Octanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

NAGly 26:6/19:2

NAGly 26:6/19:2

C47H75NO5 (733.5645)


   

NAGly 24:6/21:2

NAGly 24:6/21:2

C47H75NO5 (733.5645)


   

NAGly 26:7/19:1

NAGly 26:7/19:1

C47H75NO5 (733.5645)


   

Lnape 8:0/N-27:0

Lnape 8:0/N-27:0

C40H80NO8P (733.5621)


   

Lnape 9:0/N-26:0

Lnape 9:0/N-26:0

C40H80NO8P (733.5621)


   

Lnape 27:0/N-8:0

Lnape 27:0/N-8:0

C40H80NO8P (733.5621)


   

Lnape 26:0/N-9:0

Lnape 26:0/N-9:0

C40H80NO8P (733.5621)


   

Lnape 18:0/N-17:0

Lnape 18:0/N-17:0

C40H80NO8P (733.5621)


   

Lnape 13:0/N-22:0

Lnape 13:0/N-22:0

C40H80NO8P (733.5621)


   

Lnape 14:0/N-21:0

Lnape 14:0/N-21:0

C40H80NO8P (733.5621)


   

Lnape 16:0/N-19:0

Lnape 16:0/N-19:0

C40H80NO8P (733.5621)


   

Lnape 15:0/N-20:0

Lnape 15:0/N-20:0

C40H80NO8P (733.5621)


   

Lnape 19:0/N-16:0

Lnape 19:0/N-16:0

C40H80NO8P (733.5621)


   

Lnape 11:0/N-24:0

Lnape 11:0/N-24:0

C40H80NO8P (733.5621)


   

Lnape 21:0/N-14:0

Lnape 21:0/N-14:0

C40H80NO8P (733.5621)


   

Lnape 22:0/N-13:0

Lnape 22:0/N-13:0

C40H80NO8P (733.5621)


   

Lnape 20:0/N-15:0

Lnape 20:0/N-15:0

C40H80NO8P (733.5621)


   

Lnape 25:0/N-10:0

Lnape 25:0/N-10:0

C40H80NO8P (733.5621)


   

Lnape 10:0/N-25:0

Lnape 10:0/N-25:0

C40H80NO8P (733.5621)


   

Lnape 24:0/N-11:0

Lnape 24:0/N-11:0

C40H80NO8P (733.5621)


   

Lnape 23:0/N-12:0

Lnape 23:0/N-12:0

C40H80NO8P (733.5621)


   

Lnape 12:0/N-23:0

Lnape 12:0/N-23:0

C40H80NO8P (733.5621)


   

Lnape 17:0/N-18:0

Lnape 17:0/N-18:0

C40H80NO8P (733.5621)


   

HexCer 8:0;3O/26:0;(2OH)

HexCer 8:0;3O/26:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 9:0;3O/25:0;(2OH)

HexCer 9:0;3O/25:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 10:0;3O/24:0;(2OH)

HexCer 10:0;3O/24:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 12:0;3O/22:0;(2OH)

HexCer 12:0;3O/22:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 13:0;3O/21:0;(2OH)

HexCer 13:0;3O/21:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 11:0;3O/23:0;(2OH)

HexCer 11:0;3O/23:0;(2OH)

C40H79NO10 (733.5704)


   

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]icosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]icosa-4,8-diene-1-sulfonic acid

C44H79NO5S (733.5679)


   

3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]hexacosane-1-sulfonic acid

3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]hexacosane-1-sulfonic acid

C44H79NO5S (733.5679)


   

3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]tetracosane-1-sulfonic acid

3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]tetracosane-1-sulfonic acid

C44H79NO5S (733.5679)


   

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyoctadecane-1-sulfonic acid

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyoctadecane-1-sulfonic acid

C44H79NO5S (733.5679)


   

(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxydocos-4-ene-1-sulfonic acid

(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxydocos-4-ene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]pentacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]pentacosa-4,8,12-triene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]icos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]icos-4-ene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyoctadec-4-ene-1-sulfonic acid

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyoctadec-4-ene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]hexacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]hexacos-4-ene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]tetracosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]tetracosa-4,8,12-triene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(4E,8E,12E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxytricosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxytricosa-4,8,12-triene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(4E,8E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]tetracosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]tetracosa-4,8-diene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

C44H79NO5S (733.5679)


   

2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxydocosane-1-sulfonic acid

2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxydocosane-1-sulfonic acid

C44H79NO5S (733.5679)


   

(4E,8E,12E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]tetracos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]tetracos-4-ene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxyoctadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxyoctadeca-4,8-diene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]icosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]icosa-4,8,12-triene-1-sulfonic acid

C44H79NO5S (733.5679)


   

(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxydocosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxydocosa-4,8-diene-1-sulfonic acid

C44H79NO5S (733.5679)


   

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]icosane-1-sulfonic acid

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]icosane-1-sulfonic acid

C44H79NO5S (733.5679)


   

Cer 15:0;2O/16:4;(3OH)(FA 16:5)

Cer 15:0;2O/16:4;(3OH)(FA 16:5)

C47H75NO5 (733.5645)


   

Cer 15:0;2O/16:5;(3OH)(FA 16:4)

Cer 15:0;2O/16:5;(3OH)(FA 16:4)

C47H75NO5 (733.5645)


   

HexCer 17:0;3O/17:0;(2OH)

HexCer 17:0;3O/17:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 14:0;3O/20:0;(2OH)

HexCer 14:0;3O/20:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 22:0;3O/12:0;(2OH)

HexCer 22:0;3O/12:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 21:0;3O/13:0;(2OH)

HexCer 21:0;3O/13:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 19:0;3O/15:0;(2OH)

HexCer 19:0;3O/15:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 20:0;3O/14:0;(2OH)

HexCer 20:0;3O/14:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 16:0;3O/18:0;(2OH)

HexCer 16:0;3O/18:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 18:0;3O/16:0;(2OH)

HexCer 18:0;3O/16:0;(2OH)

C40H79NO10 (733.5704)


   

HexCer 15:0;3O/19:0;(2OH)

HexCer 15:0;3O/19:0;(2OH)

C40H79NO10 (733.5704)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] hexacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] hexacosanoate

C40H80NO8P (733.5621)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] icosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] icosanoate

C40H80NO8P (733.5621)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] octadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] octadecanoate

C40H80NO8P (733.5621)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] nonadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] nonadecanoate

C40H80NO8P (733.5621)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] docosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] docosanoate

C40H80NO8P (733.5621)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] henicosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] henicosanoate

C40H80NO8P (733.5621)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] pentacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] pentacosanoate

C40H80NO8P (733.5621)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] tetracosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] tetracosanoate

C40H80NO8P (733.5621)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] tricosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] tricosanoate

C40H80NO8P (733.5621)


   

(3-Decanoyloxy-2-docosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Decanoyloxy-2-docosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

(3-Dodecanoyloxy-2-icosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Dodecanoyloxy-2-icosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

(2-Nonadecanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Nonadecanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

(2-Heptadecanoyloxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Heptadecanoyloxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] heptacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] heptacosanoate

C40H80NO8P (733.5621)


   

(2-Heptacosanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Heptacosanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

(3-Nonanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Nonanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

(2-Hexacosanoyloxy-3-hexanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexacosanoyloxy-3-hexanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

(2-Henicosanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Henicosanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

(3-Heptanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Heptanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] pentacosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] pentacosanoate

C40H80NO8P (733.5621)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] tetracosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] tetracosanoate

C40H80NO8P (733.5621)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] tricosanoate

C40H80NO8P (733.5621)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] docosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] docosanoate

C40H80NO8P (733.5621)


   

[(2S)-3-henicosanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-henicosanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

[(2S)-2-dodecanoyloxy-3-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-dodecanoyloxy-3-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] tricosanoate

C40H80NO8P (733.5621)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] icosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] icosanoate

C40H80NO8P (733.5621)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] henicosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] henicosanoate

C40H80NO8P (733.5621)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] pentacosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] pentacosanoate

C40H80NO8P (733.5621)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] tetracosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] tetracosanoate

C40H80NO8P (733.5621)


   

[(2S)-2-decanoyloxy-3-docosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-decanoyloxy-3-docosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H80NO8P (733.5621)


   

1,2-dihexadecanoyl-sn-glycero-3-phosphocholine

1,2-dihexadecanoyl-sn-glycero-3-phosphocholine

C40H80NO8P (733.5621)


A phosphatidylcholine 32:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl). A synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of pulmonary surfactants.

   

1-Stearoyl-2-myristoyl-sn-glycero-3-phosphocholine

1-Stearoyl-2-myristoyl-sn-glycero-3-phosphocholine

C40H80NO8P (733.5621)


A phosphatidylcholine 32:0 in which the acyl group specified at positions 1 and 2 are stearoyl and myristoyl respectively.

   

1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine

1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine

C40H80NO8P (733.5621)


A phosphatidylcholine 32:0 in which the acyl group specified at positions 1 and 2 are myristoyl and stearoyl respectively.

   

1-pentadecanoyl-2-eicosanoyl-glycero-3-phosphoethanolamine

1-pentadecanoyl-2-eicosanoyl-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

1-eicosanoyl-2-pentadecanoyl-glycero-3-phosphoethanolamine

1-eicosanoyl-2-pentadecanoyl-glycero-3-phosphoethanolamine

C40H80NO8P (733.5621)


   

PE-NMe(16:0/18:0)

PE-NMe(16:0/18:0)

C40H80NO8P (733.5621)


   

PE-NMe(14:0/20:0)

PE-NMe(14:0/20:0)

C40H80NO8P (733.5621)


   

PE-NMe(18:0/16:0)

PE-NMe(18:0/16:0)

C40H80NO8P (733.5621)


   

PE-NMe(20:0/14:0)

PE-NMe(20:0/14:0)

C40H80NO8P (733.5621)


   

PE-NMe2(15:0/18:0)

PE-NMe2(15:0/18:0)

C40H80NO8P (733.5621)


   

PE-NMe2(18:0/15:0)

PE-NMe2(18:0/15:0)

C40H80NO8P (733.5621)


   

1-dodecanoyl-2-eicosanoyl-sn-glycero-3-phosphocholine

1-dodecanoyl-2-eicosanoyl-sn-glycero-3-phosphocholine

C40H80NO8P (733.5621)


   

1-heptadecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

1-heptadecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C40H80NO8P (733.5621)


   

phosphatidylcholine 32:0

phosphatidylcholine 32:0

C40H80NO8P (733.5621)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 32 carbons in total with 0 double bonds.

   

Phosphatidylcholine 16:0/16:0

Phosphatidylcholine 16:0/16:0

C40H80NO8P (733.5621)


A phosphatidylcholine 32:0 in which the acyl groups at C-1 and C-2 are both hexadecanoyl.

   

eicosanoic acid [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-(1-oxopentadecoxy)propan-2-yl] ester

eicosanoic acid [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-(1-oxopentadecoxy)propan-2-yl] ester

C40H80NO8P (733.5621)


   

Hex1Cer(34:0)

Hex1Cer(t18:0_16:0(1+O))

C40H79NO10 (733.5704)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MePC(31:0)

MePC(15:0_16:0)

C40H80NO8P (733.5621)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(33:0)

dMePE(16:0_17:0)

C40H80NO8P (733.5621)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

HexCer 8:0;O3/26:0;O

HexCer 8:0;O3/26:0;O

C40H79NO10 (733.5704)


   
   

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-16-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadecan-2-yl]-2-hydroxyhexadecanimidic acid

(2r)-n-[(2s,3s,4r)-3,4-dihydroxy-16-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadecan-2-yl]-2-hydroxyhexadecanimidic acid

C40H79NO10 (733.5704)


   

2-aminoethoxy(2-(hexadecanoyloxy)-3-[(10-methyloctadecanoyl)oxy]propoxy)phosphinic acid

2-aminoethoxy(2-(hexadecanoyloxy)-3-[(10-methyloctadecanoyl)oxy]propoxy)phosphinic acid

C40H80NO8P (733.5621)


   

n-(3,4-dihydroxy-16-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadecan-2-yl)-2-hydroxyhexadecanimidic acid

n-(3,4-dihydroxy-16-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadecan-2-yl)-2-hydroxyhexadecanimidic acid

C40H79NO10 (733.5704)


   

2-aminoethoxy((2r)-2-(hexadecanoyloxy)-3-{[(10r)-10-methyloctadecanoyl]oxy}propoxy)phosphinic acid

2-aminoethoxy((2r)-2-(hexadecanoyloxy)-3-{[(10r)-10-methyloctadecanoyl]oxy}propoxy)phosphinic acid

C40H80NO8P (733.5621)